Valuation AstraZeneca PLC Berne S.E.

Stocks

End-of-day quote Berne S.E. Other stock markets 2026-06-15			5-day change	1st Jan Change
141.67 ^CHF	-3.68%		-3.68%	-2.20%

06-19	FTSE 100 flat as investors weigh US-Iran peace talks, energy stocks support	RE
06-19	WINNERS & LOSERS: Broker downgrade hits Admiral; PPHE bid collapses	AN

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	182,034	209,442	209,268	203,171	287,813	271,528	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	-5.66%	-	-
Enterprise Value (EV) ¹	206,417	232,365	231,778	227,741	311,187	290,773	283,533	275,529
Change	-	12.57%	-0.25%	-1.74%	36.64%	-6.56%	-2.49%	-2.82%
P/E	1,469x	64.1x	35.4x	29.1x	28.4x	21.9x	19.1x	16.5x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	5.11x	4.4x	3.59x
PEG	-	0x	0.4x	1.6x	0.6x	1x	1.3x	1x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	4.29x	4.04x	3.79x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	4.59x	4.22x	3.85x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	13x	11.6x	10.3x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	13.7x	12x	10.6x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	27.9x	20.6x	18.1x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.59%	4.85%	5.52%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.337	3.524	3.659
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	1.91%	2.01%	2.09%
EPS ²	0.08	2.11	3.81	4.5	6.54	7.979	9.145	10.61
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	41.8%	38.5%	34.5%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,321	67,157	71,556
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,337	24,470	26,751
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,241	23,587	25,911
Net income ¹	112	3,288	5,961	7,035	10,225	12,488	14,137	16,137
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	19,245	12,005	4,001
Reference price ²	117.51	135.16	135.02	131.05	185.60	175.07	175.07	175.07
Nbr of stocks (in thousands)	1,549,159	1,549,528	1,549,926	1,550,317	1,550,726	1,550,996	-	-
Announcement Date	2/10/22	2/9/23	2/8/24	2/6/25	2/10/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.01x	11.69x	23.99x	0.62%	980B
JOHNSON & JOHNSON	24.41x	5.63x	15.32x	2.34%	550B
ABBVIE INC.	26.86x	6.49x	13.28x	3.17%	382B
ROCHE HOLDING AG	17.04x	4.24x	10.43x	3.13%	316B
NOVARTIS AG	20.28x	5.27x	12.78x	3.05%	268B
NOVO NORDISK A/S	13x	4.83x	9.94x	3.87%	199B
AMGEN INC.	21.95x	5.91x	10.33x	2.99%	182B
GILEAD SCIENCES, INC.	-44.34x	5.36x	29.54x	2.62%	154B
PFIZER INC.	11.79x	3.11x	7.57x	6.95%	144B
Average	13.67x	5.84x	14.80x	3.19%	352.72B
Weighted average by Cap.	21.21x	7.28x	16.76x	2.4%